Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Gabriel Steg

Showing results (21-30 of 242) with videos related to

Pageof 25
Sort By:
Journal of the American College of Cardiology|January 29, 2025
Reply: Plasma Triglyceride Reduction and Cardiovascular Risk in ODYSSEY Outcomes Trial: Interpret With CautionDoron Zahger, Gregory G Schwartz, Michael Szarek, et al.
Journal of the American College of Cardiology|June 11, 2025
Perioperative Management of Patients Taking Factor XI Inhibitors: Small Steps Toward a Giant LeapJames D Douketis, P Gabriel Steg, Suzanne C Cannegieter, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|December 4, 2025
Diagnosis, risk stratification, and early management of non-ST-segment elevation acute coronary syndromeMila Kovacevic, Daniel A Jones, Holger Thiele, et al.
Lancet (London, England)|September 2, 2008
Heart rate as a prognostic risk factor in patients with coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a subgroup analysis of a randomised controlled trialKim Fox, Ian Ford, P Gabriel Steg, et al.
The American Journal of Cardiology|January 10, 2002
Impact of smoking on the incidence and survival of cardiogenic shock complicating acute myocardial infarction treated with reperfusion therapyDominique Himbert, Jean-Louis Golmard, Jean-Michel Juliard, et al.
European Heart Journal|January 13, 2009
Patients with peripheral arterial disease in the CHARISMA trialPatrice P Cacoub, Deepak L Bhatt, P Gabriel Steg, et al.
Plos One|February 6, 2014
Clinical characteristics, management, and control of permanent vs. nonpermanent atrial fibrillation: insights from the RealiseAF surveyJan Murin, Lisa Naditch-Brûlé, Sandrine Brette, et al.
Critical Pathways in Cardiology|August 22, 2022
International Perspectives on the Impact of the COVID-19 Pandemic on Adherence to Prescribed Dual Antiplatelet Therapy: A Window Into Acute Cardiovascular CareCharles V Pollack, P Gabriel Steg, Stefan James, et al.
Chest|August 11, 2004
Acute coronary syndromes without chest pain, an underdiagnosed and undertreated high-risk group: insights from the Global Registry of Acute Coronary EventsDavid Brieger, Kim A Eagle, Shaun G Goodman, et al.
The American Journal of Cardiology|May 5, 2007
Comparisons of guideline-recommended therapies in patients with documented coronary artery disease having percutaneous coronary intervention versus coronary artery bypass grafting versus medical therapy only (from the REACH International Registry)Benjamin A Steinberg, P Gabriel Steg, Deepak L Bhatt, et al.
Pageof 25

Showing results (21-30 of 242) with videos related to

Sort By:
Pageof 25
Journal of the American College of Cardiology|January 29, 2025
Reply: Plasma Triglyceride Reduction and Cardiovascular Risk in ODYSSEY Outcomes Trial: Interpret With CautionDoron Zahger, Gregory G Schwartz, Michael Szarek, et al.
Journal of the American College of Cardiology|June 11, 2025
Perioperative Management of Patients Taking Factor XI Inhibitors: Small Steps Toward a Giant LeapJames D Douketis, P Gabriel Steg, Suzanne C Cannegieter, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|December 4, 2025
Diagnosis, risk stratification, and early management of non-ST-segment elevation acute coronary syndromeMila Kovacevic, Daniel A Jones, Holger Thiele, et al.
Lancet (London, England)|September 2, 2008
Heart rate as a prognostic risk factor in patients with coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a subgroup analysis of a randomised controlled trialKim Fox, Ian Ford, P Gabriel Steg, et al.
The American Journal of Cardiology|January 10, 2002
Impact of smoking on the incidence and survival of cardiogenic shock complicating acute myocardial infarction treated with reperfusion therapyDominique Himbert, Jean-Louis Golmard, Jean-Michel Juliard, et al.
European Heart Journal|January 13, 2009
Patients with peripheral arterial disease in the CHARISMA trialPatrice P Cacoub, Deepak L Bhatt, P Gabriel Steg, et al.
Plos One|February 6, 2014
Clinical characteristics, management, and control of permanent vs. nonpermanent atrial fibrillation: insights from the RealiseAF surveyJan Murin, Lisa Naditch-Brûlé, Sandrine Brette, et al.
Critical Pathways in Cardiology|August 22, 2022
International Perspectives on the Impact of the COVID-19 Pandemic on Adherence to Prescribed Dual Antiplatelet Therapy: A Window Into Acute Cardiovascular CareCharles V Pollack, P Gabriel Steg, Stefan James, et al.
Chest|August 11, 2004
Acute coronary syndromes without chest pain, an underdiagnosed and undertreated high-risk group: insights from the Global Registry of Acute Coronary EventsDavid Brieger, Kim A Eagle, Shaun G Goodman, et al.
The American Journal of Cardiology|May 5, 2007
Comparisons of guideline-recommended therapies in patients with documented coronary artery disease having percutaneous coronary intervention versus coronary artery bypass grafting versus medical therapy only (from the REACH International Registry)Benjamin A Steinberg, P Gabriel Steg, Deepak L Bhatt, et al.
Pageof 25